Drug treatment in Asia

AFRICA

AMERICAS

ASIA

EUROPE

OCEANIA

PRIMARY DRUG AMONG PERSONS TREATED FOR DRUG PROBLEMS IN ASIA

2017 (or latest year available)

 

Country/Territory

Source

Treatment
 year

Distribution of main drugs in percentages*

Treatment
provided**

Data
Primarily
reflect

Cannabis

Opioids

Cocaine

ATS

Tranquillizers
and sedatives

Hallucinogens

Solvents and
inhalants

Other †

Afghanistan

ARQ

2015

7.2%

92.8%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

18,609

a

Armenia

ARQ

2015

3.4%

95.1%

0.0%

0.0%

1.5%

0.0%

0.0%

0.0%

267

 

Azerbaijan

ARQ

2017

6.3%

81.2%

0.0%

0.0%

12.5%

0.0%

0.0%

0.0%

2,802

a

Bangladesh

DAINAP

2007/ 2009***

15.0%

76.9%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

3,800

a

Bhutan

ARQ

2010

 

 

 

 

 

 

 

 

74

 

Brunei Darussalam

ARQ

2017

0.0%

0.0%

0.0%

100.0%

0.0%

0.0%

0.0%

0.0%

103

 

China

ARQ

2016

0.0%

100.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

162,000

k

Cambodia

DAINAP

2017

0.0%

0.9%

0.0%

98.8%

0.0%

0.0%

0.0%

0.3%

15,737

 

Georgia

ARQ/Gov.

2017

14.3%

73.8%

0.1%

5.4%

4.7%

0.0%

0.0%

1.6%

10,370††

a

Hong Kong SAR, China

Gov./ARQ

2008/ 2009***

6.0%

57.9%

0.0%

8.7%

0.0%

0.0%

0.0%

27.4%

12,557

j

India

ARQ

2015-2016

26.2%

49.2%

0.3%

0.4%

11.1%

 

3.0%

9.8%

15,250

k, d

Indonesia

ARQ

2015-2017

 

 

 

 

 

 

 

 

26,054

k

Iran (Islamic Republic of)

ARQ

2017

 

 

 

 

 

 

 

 

981,738

a

Israel

ARQ

2017

0.0%

100.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

5,350

k

Japan

Gov./DAINAP

2005/ 2012***

2.3%

0.0%

0.0%

55.1%

0.0%

0.0%

14.5%

28.2%

18,131

 

Jordan

ARQ

2015

0.0%

3.6%

0.1%

12.4%

0.0%

0.5%

0.0%

0.0%

1,448

k

Kazakhstan

ARQ

2017

2.6%

50.3%

0.0%

1.1%

0.3%

 

0.8%

44.9%

5,102

 

Kuwait

ARQ

2009

28.4%

31.2%

0.5%

22.3%

16.1%

0.0%

1.5%

0.0%

197

d,f

Kyrgyzstan

ARQ

2016

20.0%

57.4%

0.0%

0.0%

0.0%

0.0%

4.7%

17.9%

190

b, c

Lao People's Democratic Republic

DAINAP

2015

0.1%

0.7%

0.0%

99.2%

0.0%

0.0%

0.0%

0.0%

1,419

 

Lebanon

ARQ

2017

22.3%

38.5%

20.5%

9.1%

8.3%

0.0%

0.0%

1.3%

2,341

k

Macao SAR, China

ARQ

2016

3.3%

43.3%

3.3%

11.3%

0.3%

 

 

30.7%

573

k

Malaysia

ARQ

2017

4.0%

37.9%

0.0%

58.0%

0.0%

0.0%

0.0%

0.0%

26,791

 

Maldives

ARQ

2003

13.0%

87.0%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

126

d,e

Mongolia

ARQ

2013

6.7%

13.3%

0.0%

3.3%

73.3%

3.3%

0.0%

0.0%

30

a

Myanmar

ARQ

2017

0.3%

83.0%

0.0%

13.0%

0.0%

0.0%

0.0%

3.6%

7,536

a

Nepal

ARQ

2006

 

 

 

 

 

 

 

 

900

a

Oman

ARQ

2017

34.0%

41.0%

0.0%

2.1%

22.2%

0.2%

0.5%

0.0%

369

a

Pakistan

ARQ

2017

 

 

 

 

 

 

 

 

1,064

b

Philippines

ARQ

2017

18.1%

0.7%

0.6%

79.6%

0.0%

1.0%

0.0%

0.1%

4,045

a

Qatar

ARQ

2008

 

 

 

 

 

 

 

 

150

a,d

Korea (Republic of)

ARQ

2017

25.5%

0.2%

0.4%

68.1%

5.1%

0.8%

0.0%

0.0%

986

k, c,d

Saudi Arabia

ARQ

2017

26.8%

8.1%

0.0%

54.1%

8.4%

0.0%

0.6%

2.1%

9,879

k

Singapore

ARQ

2017

6.1%

12.1%

0.0%

75.3%

0.2%

0.0%

1.2%

5.1%

1,166

k

Syrian Arab Republic

ARQ

2006

0.2%

94.9%

0.9%

0.0%

4.1%

0.0%

0.0%

0.0%

674

 

Sri Lanka

ARQ

2017

17.9%

82.1%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

2,706

a

Taiwan, Province of China

NBCD   DOH

2009

0.1%

73.1%

 

22.3%

4.2%

 

 

 

19,125

d

Tajikistan

ARQ

2016

0.5%

91.8%

 

 

 

 

 

 

560

a

Thailand

DAINAP

2017

7.2%

3.4%

0.0%

85.6%

0.0%

0.0%

0.2%

3.6%

205,147

 

Turkmenistan

ARQ

2016

4.9%

95.1%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

1,602

a

United Arab Emirates

ARQ

2008/ 2009***

35.7%

64.3%

0.0%

0.0%

0.0%

0.0%

0.0%

0.0%

55

 

Uzbekistan

ARQ

2017

32.3%

51.8%

0.0%

0.0%

9.7%

0.0%

0.9%

5.2%

2,202

k

Viet nam

DAINAP

2017

 

 

 

 

0.0%

0.0%

 

 

34,620

 

 

Notes                                                                                                                                                                                        

*      Definitions of treatment interventions, recording practices (including counting rules) and methods for determining the primary drug of abuse differ from country to country; percentages may fail to add up to 100 percent owing to incomplete reporting, gaps in identifying primary drug of abuse and treatment for multiple drugs.                                                                                                                                                                        

In cases where the total of the reported values by drug type exceeded the reported value for all treatment, the percentages are expressed as a proportion of the total.                                                                                          

**    Figures may reflect the number of persons or treatment episodes depending on the Member State; figures exclude alcohol and nicotine.     

***  If multiple years are given, the second year specified is for the number of people treated (second to the last column).                    

†    In addition to miscellaneous and unspecified drugs, the category "Other" includes substances not under international control.                                    

†† Georgia: Data represents treatment episodes rather than the number of treatment entrants.                                                                                                

Sources:                                                                                                                                                                                     

UNODC, Annual Report Questionnaire (ARQ)                                                                                                                  

UNODC Drug Abuse Information Network for Asia and the Pacific (DAINAP).   

National Bureau of Controlled Drugs (NBCD), Department of Health (DOH), Taiwan      

Government (Gov.)